| 查看: 216 | 回复: 1 | ||
| 当前主题已经存档。 | ||
[资源]
【转贴】Nature Medicine2006年度十大医学进展
|
||
|
1 The tumor suppressor p53 was thought to protect from cancer by monitoring cells for DNA damage and eliminating potentially precancerous cells. But DNA damage may be irrelevant to p53’s protective effects, researchers reported in September. Instead a second tumor suppressor, p19ARF, may be the crucial signal for p53 to kill precancerous cells. 2.Three independent groups this year showed that HIV exhausts the ability of the immune system to combat infection by increasing the expression of a signaling molecule on CD8+ T cells and hampering their ability to respond to infected cells. The findings suggest a way to kick-start the immune system in HIV-infected individuals. 3 The link between feeding and the brain’s sensing of nutrient levels was further cemented this year when scientists showed that injecting leucine into mouse brains activates mTOR, an enzyme known to regulate cell signaling and reduce eating. Rapamycin, an mTOR inhibitor, blocks this effect. The results suggest a possible target for obesity drugs. 4.Treating cancer by targeting the stem cells that give rise to tumors runs the risk of also killing normal stem cells, such as those that generate blood. Two groups this year identified key differences between normal and leukemia-initiating stem cells that might help target only cancer stem cells while sparing their normal counterparts. 5.Three factors needed to drive hematopoietic stem cells from their niche in the bone marrow into the circulation were revealed this year. The stem cells’mobilization requires sympathetic nervous system activity, a calcium-sensing receptor on their cell surface to tether the cells to the bone niche and the differentiation of osteoclasts, which releases enzymes to cleave tethering proteins. 6.Antidepressants may take several weeks to act, and their effects can extend for months after their use has been discontinued. How? Depression in mice induces remodeling of nuclear chromatin, altering gene expression, researchers reported in April. These epigenetic changes are reversed by antidepressants and may explain the drugs’ long-lasting effects. 7.A new class of CD4+ T cells, called TH17 cells, is thought to promote autoimmune disease. Two reports this year revealed that these cells are surprisingly closely linked to the protective regulatory T cells that dampen harmful immune responses: the cytokine TGF-β drives the development of both types. 8 Activity of the γ-secretase enzy.me is crucial in Alzheimer disease. Researchers showed in September that presenilins, key components of the γ-secretase complex, form calcium channels in the endoplasmic reticulum. This channel function is independent of γ-secretase activity and is absent in mutant presenilins linked to genetic forms of Alzheimer disease, challenging the prevailing amyloid hypothesis. 9.Two groups this year gave paralyzed individuals hope with remarkable advances in the area of brain-computer interfaces-or neuromotor prostheses. The interfaces enable a device implanted in the brain to translate electrical signals from neurons into external movement, allowing a tetraplegic man to move an electronic cursor as well as a robotic arm by thought. A second group increased the response speed of such interfaces. 10.Two studies this year showed how the activity of TGF-β cytokines contributes to vascular disease. The protein emilin prevents high blood pressure in mice caused by too much TGF-β activity. Higher levels of another antagonist, soluble endoglin, are present in pregnant women who develop pre-eclampsia a major cause of maternal and fetal death and trigger pre-eclamptic symptoms in mice. [ Last edited by goses on 2006-12-10 at 21:38 ] |
» 猜你喜欢
论文被拒,编辑说提供的原始数据信息不足
已经有14人回复
2022年国青预算有要求吗?网站上没有上传预算说明说的页面呢?
已经有3人回复
血液系统论文润色/翻译怎么收费?
已经有147人回复
投稿时选择了open access,文章接收能修改成不收费吗?
已经有2人回复
卡波姆不呈凝胶状
已经有2人回复
有哪位大咖有临床预测模型类课题的研究思路或者本子可以分享学习一下,万分感谢
已经有0人回复
请教下,这个表述是否上会
已经有8人回复
考博求助,求博导推荐
已经有3人回复
南京中医药大学招调剂!!
已经有0人回复
wiley的online proof需要给杂志社发送回复邮件吗?
已经有6人回复
2楼2006-12-16 12:46:32











回复此楼